Cite

HARVARD Citation

    Gregory, M. et al. (2019). Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort. Inflammatory bowel diseases. 25 (9), pp. 1569-1576. [Online]. 
  
Back to record